I know you have Iomi on your list of biotech buyouts and just noticed this article on Iomai's transcutaneous vaccination technology (now part of Intercell).
I always thought this had great possibilities. Do you know of anyway to invest in it or is it now just a small part of a huge foreign biotech's portfolio that wouldn't be worth the effort?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.